A detailed history of New Edge Wealth, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, New Edge Wealth, LLC holds 37,129 shares of REGN stock, worth $29.1 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
37,129
Previous 36,271 2.37%
Holding current value
$29.1 Million
Previous $38.1 Million 2.39%
% of portfolio
0.72%
Previous 0.84%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1024.09 - $1201.76 $878,669 - $1.03 Million
858 Added 2.37%
37,129 $39 Million
Q2 2024

Aug 01, 2024

BUY
$883.2 - $1071.19 $9,715 - $11,783
11 Added 0.03%
36,271 $38.1 Million
Q1 2024

May 06, 2024

BUY
$902.69 - $993.35 $3.2 Million - $3.52 Million
3,541 Added 10.82%
36,260 $34.9 Million
Q4 2023

Jan 29, 2024

BUY
$775.18 - $881.7 $3.32 Million - $3.78 Million
4,287 Added 15.08%
32,719 $28.7 Million
Q3 2023

Nov 08, 2023

BUY
$692.45 - $844.37 $4.92 Million - $5.99 Million
7,099 Added 33.28%
28,432 $23.4 Million
Q2 2023

Aug 09, 2023

BUY
$700.03 - $830.35 $515,922 - $611,967
737 Added 3.58%
21,333 $15.3 Million
Q1 2023

May 08, 2023

BUY
$680.49 - $826.97 $668,921 - $812,911
983 Added 5.01%
20,596 $16.9 Million
Q4 2022

Feb 14, 2023

BUY
$705.89 - $766.39 $617,653 - $670,591
875 Added 4.67%
19,613 $14.2 Million
Q3 2022

Nov 14, 2022

BUY
$573.97 - $724.32 $1.07 Million - $1.35 Million
1,864 Added 11.05%
18,738 $12.9 Million
Q2 2022

Aug 09, 2022

BUY
$548.35 - $738.84 $313,107 - $421,877
571 Added 3.5%
16,874 $9.98 Million
Q1 2022

May 10, 2022

BUY
$595.12 - $698.43 $4.16 Million - $4.88 Million
6,989 Added 75.04%
16,303 $11.4 Million
Q4 2021

Jan 31, 2022

BUY
$543.48 - $670.97 $5.06 Million - $6.25 Million
9,314 New
9,314 $5.88 Million
Q2 2021

Aug 11, 2021

SELL
$472.8 - $558.54 $561,686 - $663,545
-1,188 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$446.73 - $548.2 $530,715 - $651,261
1,188 New
1,188 $562,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $83.9B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track New Edge Wealth, LLC Portfolio

Follow New Edge Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Wealth, LLC with notifications on news.